Willow Biosciences Shares Annual Meeting Voting Outcomes and Future Plans
Willow Biosciences: Annual Meeting Results and Future Directions
Willow Biosciences Inc. (TSX: WLLW, OTCQB: CANSF), a prominent player in the biotechnology sector, has officially disclosed the outcomes of its annual general and special meeting held on April 25, 2025. This meeting witnessed participation from a substantial number of shareholders; approximately 59.2 million shares, or 40.88% of the total issued and outstanding shares of the company, were represented.
Election of Directors
During this pivotal assembly, shareholders voted on and approved a range of significant matters. One of the key highlights was the election of five directors to steer the company’s future. The following individuals were elected, along with their respective vote tallies:
| Director | Votes For | Percentage For | Votes Withheld | Percentage Withheld |
|---|---|---|---|---|
| ----- | --- | ---- | ---- | ------- |
| Dr. Chris Savile | 46,902,346 | 88.3% | 6,234,676 | 11.7% |
| Dr. Jim Lalonde | 46,965,380 | 88.4% | 6,171,642 | 11.6% |
| Donald Archibald | 44,900,287 | 84.5% | 8,236,735 | 15.5% |
| Raffi Asadorian | 46,963,057 | 88.4% | 6,173,965 | 11.6% |
| Al Foreman | 46,900,723 | 88.3% | 6,236,299 | 11.7% |
These directors will serve for the upcoming year, bringing a mix of experience and expertise to Willow’s board.
Approval of Significant Resolutions
The shareholders also approved additional important resolutions during the meeting.
- - Appointment of Auditor: KPMG LLP was selected as the company's auditor for the forthcoming year, receiving 51,882,364 votes in favour, amounting to 87.6%.
- - Sale of Epimeron USA, Inc.: The proposed divestiture of the shares of Epimeron USA, Inc., a wholly-owned subsidiary of Willow, also garnered strong support, with 46,996,397 votes (88.4%) in favour.
- - Name Change Authorization: A resolution permitting the board to amend the Corporation's articles to potentially rename Willow Biosciences Inc. to
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.